Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (311-320 of 368) with videos related to

Pageof 37
Sort By:
Biomolecules|July 27, 2024
Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic NicheShankar Suman, Wendy K Nevala, Alexey A Leontovich, et al.
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
American Journal of Clinical Oncology|January 30, 2013
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675Roxana S Dronca, Jacob B Allred, Domingo G Perez, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 26, 2012
Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remissionBrendan P McMenomy, A Nicholas Kurup, Geoffrey B Johnson, et al.
Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trialsEdward L Korn, Ping-Yu Liu, Sandra J Lee, et al.
Cancer Research|March 11, 2026
Engineering T Cells with a Tumor-Reactive Chimeric T Cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor ResponsesJoey C Magno, Jitao Guo, Spencer C Hall, et al.
Science Advances|April 1, 2026
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodiesXingxing Zhu, Yue Yu, Shiju Chen, et al.
Leukemia|March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myelomaL F Porrata, M A Gertz, S M Geyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Pageof 37

Showing results (311-320 of 368) with videos related to

Sort By:
Pageof 37
Biomolecules|July 27, 2024
Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic NicheShankar Suman, Wendy K Nevala, Alexey A Leontovich, et al.
Leukemia & Lymphoma|October 27, 2006
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphomaIvana N M Micallef, Ellen D Remstein, Stephen M Ansell, et al.
American Journal of Clinical Oncology|January 30, 2013
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675Roxana S Dronca, Jacob B Allred, Domingo G Perez, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 26, 2012
Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remissionBrendan P McMenomy, A Nicholas Kurup, Geoffrey B Johnson, et al.
Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trialsEdward L Korn, Ping-Yu Liu, Sandra J Lee, et al.
Cancer Research|March 11, 2026
Engineering T Cells with a Tumor-Reactive Chimeric T Cell Receptor Reduces Exhaustion and Promotes Persistence to Elicit Enhanced Antitumor ResponsesJoey C Magno, Jitao Guo, Spencer C Hall, et al.
Science Advances|April 1, 2026
Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodiesXingxing Zhu, Yue Yu, Shiju Chen, et al.
Leukemia|March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myelomaL F Porrata, M A Gertz, S M Geyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosisLuis F Porrata, Morie A Gertz, Mark R Litzow, et al.
Pageof 37